ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 25, 2003

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

In Brief: Mauer Resigns St. Jude Director; Breslow Named DRCCA Board Chairman; Senate Considers Line Items

August 20, 1982

National Health Organizations Warn of Risks in Indoor Tanning

April 29, 2011

Randomization With Options Stimulates Sedmental Accrual

February 22, 1980